Thyrotropin, but not a polymorphism in type II deiodinase, predicts response to paroxetine in major depression

European Journal of Endocrinology

Volumn 154, Issue 6, 2006, Pages 819-825

  Brouwer, Jantien P ^a   Appelhof, Bente C ^a   Peeters, Robin P ^b   Hoogendijk, Witte J G ^c   Huyser, Jochanan ^a   Schene, Aart H ^a   Tijssen, Jan G P ^a   Van Dyck, Richard ^c   Visser, Theo J ^b   Wiersinga, Wilmar M ^a   Fliers, Eric ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ANTIDEPRESSANT AGENT; LIOTHYRONINE; PAROXETINE; THREONINE; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROXINE; THYROXINE DEIODINASE;

ADULT; ARTICLE; BRAIN REGION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; GENE SEQUENCE; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOSITY; HORMONE SYNTHESIS; HUMAN; HYPOTHALAMUS HYPOPHYSIS THYROID SYSTEM; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; OUTPATIENT; PATIENT SELECTION; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; WILD TYPE;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; IODIDE PEROXIDASE; MALE; MIDDLE AGED; PAROXETINE; POLYMORPHISM, GENETIC; THYROTROPIN;

EID: 33745712826     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.02155     Document Type: Article

References (39)

1. Kornstein SG & Schneider RK. Clinical features of treatment-resistant depression. Journal of Clinical Psychiatry 2001 62 Suppl 16 18-25.
2. Pop VJ, Maartens LH, Leusink G et al. Are autoimmune thyroid dysfunction and depression related? Journal of Clinical Endocrinology and Metabolism 1998 83(9) 3194-3197.
3. Nemeroff CB, Simon JS, Haggerty JJ, Jr & Evans DL. Antithyroid antibodies in depressed patients. American Journal of Psychiatry 1985 142(7) 840-843.
4. Jackson IM & Luo LG. Antidepressants inhibit the glucocorticoid stimulation of thyrotropin releasing hormone expression in cultured hypothalamic neurons. Journal of Investigative Medicine 1998 46(9) 470-474.
5. Kirkegaard C & Faber J. The role of thyroid hormones in depression. European Journal of Endocrinology 1998 138(1) 1-9.
6. Duval F, Mokrani MC, Crocq MA, Jautz M, Barley P, Diep TS & Macher JP. Effect of antidepressant medication on morning and evening thyroid function tests during a major depressive episode. Archives of General Psychiatry 1996 53(9) 833-840.
7. Sullivan PF, Wilson DA, Mulder RT & Joyce PR. The hypothalamic-pituitary-thyroid axis in major depression. Acta Psychiatrica Scandinavia 1997 95(5) 370-378.
8. Fava M, Labbate LA, Abraham ME & Rosenbaum JF. Hypothyroidism and hyperthyroidism in major depression revisited. Journal of Clinical Psychiatry 1995 56(5) 186-192.
9. Sokolov ST, Kutcher SP & Joffe RT. Changes in thyroid hormone levels associated with desipramine response in adolescent depression. Progress in Neuropsychopharmacology Biology and Psychiatry 1996 20(6) 1053-1063.
10. Rao ML, Ruhrmann S, Retey B, Liappis N, Fuger J, Kraemer M, Kasper S & Moller HJ. Low plasma thyroid indices of depressed patients are attenuated by antidepressant drugs and influence treatment outcome. Pharmacopsychiatry 1996 29(5) 180-186.
11. Baumgartner A, Graf KJ, Kurten I & Meinhold H. The hypothalamic-pituitary-thyroid axis in psychiatric patients and healthy subjects: Parts 1-4. Psychiatry Research 1988 24(3) 271-332.
12. Hoflich G, Kasper S, Danos P & Schmidt R. Thyroid hormones, body temperature, and antidepressant treatment. Biological Psychiatry 1992 31(8) 859-862.
13. Strieder TG, Prummel ME, Tijssen JG, Endert E & Wiersinga WM. Risk factors for and prevalence of thyroid disorders in a cross-sectional study among healthy female relatives of patients with autoimmune thyroid disease. Clinical Endocrinology (Oxf) 2003 59(3) 396-401.
14. Bianco AC, Salvatore D, Gereben B, Berry MJ & Larsen PR. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocrine Reviews 2002 23(1) 38-89.
15. Eravci M, Pinna G, Meinhold H & Baumgartner A. Effects of pharmacological and nonpharmacological treatments on thyroid hormone metabolism and concentrations in rat brain. Endocrinology 2000 141(3) 1027-1040.
16. Baumgartner A, Dubeyko M, Campos-Barros A, Eravci M & Meinhold H. Subchronic administration of fluoxetine to rats affects triiodothyronine production and deiodination in regions of the cortex and in the limbic forebrain. Brain Research 1994 635(1-2) 68-74.
17. Campos-Barros A, Mcinhold H, Stula M, Muller F, Kohler R, Eravci M, Putzien O & Baumgartner A. The influence of desipramine on thyroid hormone metabolism in rat brain. Journal of Pharmacology and Experimental Therapeutics 1994 268(3) 1143-1152.
18. Atterwill CK. Effect of acute and chronic tri-iodothyronine (T3) administration to rats on central 5-HT and dopamine-mediated behavioural responses and related brain biochemistry. Neuropharmacology 1981 20(2) 131-144.
19. 4. Molecular Endocrinology 2001 15(12) 2137-2148.
20. Mentuccia D, Proietti-Pannunzi L, Tanner K, Bacci V, Pollin TI, Poehlman ET, Shuldiner AR & Celi FS. Association between a novel variant of the human type 2 deiodinase gene Thr92Ala and insulin resistance: evidence of interaction with the Trp64Arg variant of the beta-3-adrenergic receptor. Diabetes 2002 51(3) 880-883.
21. Peeters RP, van Toor H, Klootwijk W, de Rijke YB, Kuiper GG, Uitterlinden AG & Visser TJ. Polymorphisms in thyroid hormone pathway genes are associated with plasma TSH and iodothyronine levels in healthy subjects. Journal of Clinical Endocrinology and Metabolism 2003 88(6) 2880-2888.
22. Appelhof BC, Brouwer JP, Van Dyck R, Fliers E, Hoogendijk WJ, Huyser J, Schene AH, Tijssen JG & Wiersinga WM. Triiodothyronine addition to paroxetine in the treatment of major depressive disorder. Journal of Clinical Endocrinology and Metabolism 2004 89(12) 6271-6276.
23. Diagnostic and Statistical Manual of Mental Disorders. 4th edn:DSM-IV. ed. Washington, D.C: American Psychiatric Association, 1994.
24. Heuser I, Yassouridis A & Holsboer F. The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders. Journal of Psychiatric Research 1994 28(4) 341-356.
25. Rush AJ, Giles DE, Schlesser MA, Orsolak PJ, Weissenburger JE, Fotton CL, Fairchild CJ & Roffwarg HP. Dexamethasone response, thyrotropin-releasing hormone stimulation, rapid eye movement latency, and subtypes of depression. Biological Psychiatry 1997 41(9) 915-928.
26. Hofmann PJ, Nutzinger DO, Kotter MR & Herzog G. The hypothalamic-pituitary-thyroid axis in agoraphobia, panic disorder, major depression and normal controls. Journal of Affective Disorders 2001 66(1) 75-77.
27. Wiersinga WM. The interpretation of the thyroid stimulating hormone (TSH) assay. Nederlands Tijdschrift voor Geneeskunde 2003 147(24) 1156-1158.
28. Orth DN, Shelton RC, Nicholson WE, Beck-Peccoz P, Tomarken AJ, Persani L & Loosen PT. Serum thyrotropin concentrations and bioactivity during sleep deprivation in depression. Archives of General Psychiatry 2001 58(1) 77-83.
29. Jackson IM. The thyroid axis and depression. Thyroid 1998 8(10) 951-956.
30. Brouwer JP, Appelhof BC, Hoogendijk WJ, Huyser J, Endert E, Zuketto C, Schene AH, Tijssen JG, van Dyok R, Wiersinga WM & Fliers E. Thyroid and adrenal axis in major depression: a controlled study in outpatients. European Journal of Endocrinology 2005 152(2) 185-191.
31. Alkemade A, Unmehopa UA, Brouwer JP, Hoogendijk WJ, Wiersinga WM, Swaab DF & Fliers E. Decreased thyrotropin-releasing hormone gene expression in the hypothalamic paraventricular nucleus of patients with major depression. Molecular Psychiatry 2003 8(10) 838-839.
32. Morley JE. Neuroendocrine control of thyrotropin secretion. Endocrine Reviews 1981 2(4) 396-436.
33. Kuijpens JL, Vader HL, Drexhage HA, Wiersinga WM, van Son MJ & Pop VJ. Thyroid peroxidase antibodies during gestation are a marker for subsequent depression postpartum. European Journal of Endocrinology 2001 145(5) 579-584.
34. Fountoulakis KN, Iacovides A, Grammaticos P, St Kaprinis G & Bech P. Thyroid function in clinical subtypes of major depression: an exploratory study. BMC Psychiatry 2004 4(1) 6.
35. Langer G, Koinig G, Hatzinger R, Hatzinger R, Schonbeck G, Resch F, Aschauer H, Keshavan MS & Sieghart W, Response of thyrotropin to thyrotropin-releasing hormone as predictor of treatment outcome, Prediction of recovery and relapse in treatment with antidepressants and neuroleptics. Archives of General Psychiatry 1986 43(9) 861-868.
36. Targum SD. The application of serial neuroendocrine challenge studies in the management of depressive disorder. Biological Psychiatry 1983 18(1) 3-19.
37. Re RN, Kourides IA, Ridgway EC, Weintraub BD & Maloof F. The effect of glucocorticoid administration on human pituitary secretion of thyrotropin and prolactin. Journal of Clinical Endocrinology and Metabolism 1976 43(2) 338-346.
38. Curcio-Morelli C, Gereben B, Zavacki AM, Kim BW, Huang S, Harney JW, Larsen PR & Bianco AC. In vivo dimerization of types 1, 2, and 3 iodothyronine selenodeiodinases. Endocrinology 2003 144(3) 937-946.
39. Thase ME & Rush AJ. When at first you don't succeed: sequential strategies for antidepressant nonresponders. Journal of Clinical Psychiatry 1997 58(Suppl 13) 23-29.